Clinical Trial Update: The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating liposomal bupivacaine in TAP blocks for cesarean section was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Pain | Phase 2, Phase 3 | Status: WITHDRAWN